Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T04:11:57.214Z Has data issue: false hasContentIssue false
  • English
  • Français

Results of the market-oriented reform in the Netherlands: a review

Published online by Cambridge University Press:  17 August 2015

Hans Maarse ,
Patrick Jeurissen  and
Dirk Ruwaard
Hans Maarse*
Affiliation:
Department of Health Services Research, Maastricht University, Maastricht, the Netherlands
Patrick Jeurissen
Affiliation:
Celsus Academy, Radboud University, Nijmegen and Ministry of Health, Welfare and Sports, The Hague, the Netherlands
Dirk Ruwaard
Affiliation:
Department of Health Services Research, Maastricht University, Maastricht, the Netherlands
*
*Correspondence to: Professor Hans Maarse, Maastricht University, Department of Health Services Research, Maastricht. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

The market-oriented reform in the Dutch health care system is now in its 10th year. This article offers a concise overview of some of its effects thus far on health insurance, healthcare purchasing and healthcare provision. Furthermore, attention is given to its impact on healthcare expenditures, power and trust relationships as well as the relationship between the Minister of Health and the Dutch Healthcare Authority. The reform triggered various alterations in Dutch health care some occurring quickly (e.g. health insurance), others taking longer (e.g. purchasing). These developments suggest a process of gradual transformation. The reform has instigated controversy which is increasingly framed as a power conflict between insurers and providers. Weakened consumer trust in insurers threatens the legitimacy of the reform. The relationship between Minister and Healthcare Authority appears to be more intimate than the formal independent status of this regulatory agency would suggest.

Type
Articles
Information
Health Economics, Policy and Law , Volume 11 , Issue 2 , April 2016 , pp. 161 - 178
Check for updates
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Boonen, L. and Schut, F. (2011), ‘Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system’, Health Economics, Policy and Law, 6(2): 219–235.CrossRefGoogle ScholarPubMed
Brabers, A., Reitsma-Van Rooijen, M. and De Jon, J. (2014), Barometer vertrouwen in de gezondheidszorg. Utrecht http://www.nivel.nl/consumentenpanel.Google Scholar
BS Health Consultancy (2014), ‘Zorgverzekerde kiest voor keuzevrijheid en prijs’, report BS Health Consultancy.Google Scholar
CBS (2013), Zvw; wanbetalers naar herkomst per 31-12-2012. Voorburg.Google Scholar
Commissie Borstlap (2014), ‘Het rapport van de onderzoekscommissie intern functioneren Nza’, report Commissie Borstlap.Google Scholar
Commissie Willems (1994), Onderzoek besluitvorming volksgezondheid. Kamerstuk 23.666. The Hague: Commissie Willems.Google Scholar
CPB (2015), Zorgkeuzes in kaart: analyse van beleidsopties voor de zorg van tien politieke partijen. The Hague: CPB.Google Scholar
De Nederlandse Bank (2014), ZBO-verantwoording 2013, Amsterdam.Google Scholar
Duijmelinck, D., Van de Ven, W., Van Vliet, R. and Van Kleef, R. (2013), ‘Overstapgedrag en risicoselectie op de zorgverzekeringsmarkt’, report iBMG, Erasmus University, Rotterdam.Google Scholar
Ecorys (2011), ‘Evaluatie naar verplicht eigen risico’, report Ecorys, Rotterdam.Google Scholar
Hasaart, F. (2012), ‘Incentives in the Diagnosis Treatment Combination Payment System for Special Medical Care’, Dissertation, Maastricht.Google Scholar
Helderman, J. K., Schut, F., Van den Grinten, T. and Van de Ven, W. (2005), ‘Market-oriented health care reform and policy Learning in the Netherlands’, Journal of Health Politics, Policy and Law, 30(1–2): 189–209.CrossRefGoogle ScholarPubMed
Ikkersheim, D. and Koolman, X. (2013), ‘The First Effects of Dutch Health Care Reform on Hospitals’, in D. Ikkersheim ed. The Dutch Health Care Reform: Creating Value, Amsterdam: Free University Press. (dissertation).Google Scholar
Kerpershoek, E. (2015), ‘Medical Professionals’ Responses to a DRG Performance Management System for Hospital Care in the Netherlands. Reinterpreting ‘Perverse Effects’, such as Upcoding and Patient Selection, Using Arguments of Professionalism and Managerialism’, Dissertation, Technical University Delft, Delft.Google Scholar
KPMG (2013), ‘Wie doet het met wie in de zorg’, report KPMG, Amstelveen.Google Scholar
KPMG (2015), ‘Wie doet het met wie in de zorg’, report KPMG, Amstelveen.Google Scholar
KPMG/Plexus (2014), ‘Evaluatie Zorgverzekeringswet’, report, KPMG/Plexus, Amstelveen.Google Scholar
Maarse, J., Ruwaard, D. and Spreeuwenberg, C. (2013), ‘The governance of quality management in Dutch health care: new developments and strategic challenges’, Quality Management in Health Care, 22(3): 236–247.CrossRefGoogle ScholarPubMed
Mikkers, M. and Ryan, P. (2014), ‘‘Managed competition’ for Ireland? The sincle versus multiple payer debate’, BMC Health Services Research, 14: 442.CrossRefGoogle Scholar
Ministry of Health (2013), Welfare and Sports. Artikel 8 Tegemoetkoming specifieke kosten. www.rijksbegroting.nl/2013/voorbereiding/begroting,kst173939.Google Scholar
Mol, A. (2008), The Logic of Care: Health and the Problem of Patient Choice, Abingdon: Routledge.CrossRefGoogle Scholar
Nza (Nederlandse Zorgautoriteit) (2011), Beleidsregel Toezichtkader Zorgplicht Zorgverzekeraars, reportNza, Utrecht.Google Scholar
Nza (2012a), ‘Markscan zorgverzekeringsmarkt: weergave van de markt 2008-2012’, report Nza, Utrecht.Google Scholar
Nza (2012b), ‘Marktscan medisch-specialistische zorg’, report Nza, Utrecht.Google Scholar
Nza (2012c), ‘Monitoring zelfstandige behandelcentra’, report Nza, Utrecht.Google Scholar
Nza (2013a), ‘Marktscan medisch-specialistische zorg’, report Nza, Utrecht.Google Scholar
Nza (2013b), ‘Marktscan medisch-specialistische zorg’, report Nza, Utrecht.Google Scholar
Nza (2014a), ‘Naleving acceptatieplicht door zorgverzekeraars’, report Nza, Utrecht.Google Scholar
Nza (2014b), ‘Marktscan medisch-specialistische zorg zorgverzekeringsmarkt’, report Nza, Utrecht.Google Scholar
Nza (2014c), ‘Naleving acceptatieplicht door zorgverzekeraars’, report Nza, Utrecht.Google Scholar
Okma, K. G. and Crivell, L. (2013), ‘Swiss and Dutch ‘consumer-driven’ health care: ideal model or reality?’, Health Policy, 109(2): 105–112.CrossRefGoogle ScholarPubMed
Pollitt, C., Harrison, S., Dowswell, G., Jerak-Zuiderent, S. and Bal, R. (2010), ‘Performance regimes in health care: institutions, critical junctures and the logic of escalation in England and the Netherlands’, Evaluation, 16(1): 13–29.CrossRefGoogle Scholar
Porter, M. and Teisberg, E. (2006), Redefining Health Care: Creating Value-Based Competition on Results, Boston: Harvard University Press.Google Scholar
Reitsma-Van Rooijen, M. and De Jong, J. (2014), Percentage Overstappers Afgenomen: Keuzevrijheid Minstens zo Belangrijk als Premie, Utrecht: NIVEL. (fact sheet).Google Scholar
RVZ (Raad voor de Volksgezondheid en Zorg) (2014), ‘De stem van verzekerden: advies over de legitimiteit en de governance van zorgverzekeraars’, report RVZ, Den Haag.Google Scholar
Schut, F. and van de Ven, W. (2011), ‘Effects of purchasing competition in the Dutch health system: is the glass half full or half empty?’, Health Economics, Policy and Law, 6: 109–123.CrossRefGoogle ScholarPubMed
Streeck, W. and Thelen, K. (2004), Beyond Continuity, Oxford: Oxford University Press.Google Scholar
Thomson, S., Busse, R., Crivelli, L., Van de Ven, W. and Van de Voorde, C. (2013), ‘Statutory health insurance competition in Europe: a four-country study’, Health Policy, 109: 209–225.CrossRefGoogle Scholar
Van de Bovenkamp, H., De Mul, M., Quartz, J., Weggelaar-Jansen, A. and Bal, R. (2014), ‘Institutional layering in governing healthcare quality’, Public Administration, 92(1): 208–223.CrossRefGoogle Scholar
Van de Ven, W. (1990), ‘From regulated cartel to regulated competition in the Dutch health care system’, European Economic Review, 35: 632–645.CrossRefGoogle Scholar
Van de Ven, W. and Schut, F. (2008), ‘Universal mandatory health insurance in the Netherlands’, Health Affairs, 3(2008): 371–381.Google Scholar
Van de Ven, W., Beck, K., Buchner, F., Schokkaert, E., Schut, F., Shmueli, A. and Wasem, J. (2013), ‘Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?’, Health Policy, 109: 226–245.CrossRefGoogle ScholarPubMed
VanderMeulen, L. and Van der Kwartel, A. (2012), Sturen op Doelmatigheid, Utrecht: KIWA Prismant.Google Scholar
VanderMeulen, L., Beldman, A. and Van der Kwartel, A. (2012), Productiviteitswinst in de Zorg, Utrecht: KIWA Prismant.Google Scholar
Van Kleef, R., Schut, F. and van de Ven, W. (2014), Evaluatie zorgstelsel en risicoverevening: Acht jaar na invoering Zorgverzekeringswet: succes verzekerd? Rotterdam: iBMG.Google Scholar
Vektis (2014), ‘Zorgthermometer: Verzekerden in beweging 2014’, report Vektis, Zeist.Google Scholar
Visser, J. and Hemerijck, A. (1997), A Dutch Miracle: Job Growth, Welfare Reform and Corporatism in the Netherlands, Amsterdam: Amsterdam University Press.CrossRefGoogle Scholar
Waarborgfonds voor de zorgsector (Wfz) (2014), Wfz Bulletin, 16(1).Google Scholar
Wildavsky, A. (1979), Speaking Truth to Power. The Art and Craft of Policy Analysis. Boston: Little Brown.CrossRefGoogle Scholar
WRR (Wetenschappelijke Raad voor het Regeringsbeleid) (2012), Publieke Zaken in een Marktsamenleving (report no. 87) Amsterdam: Amsterdam University Press.Google Scholar
Zuiderent-Jerak, T., Grit, K. and van der Grinten, T. (2011), Markets and public values in health care. Wetenschappelijke Raad voor het Regeringsbeleid. Den Haag (webpublication).Google Scholar